NEW YORK (GenomeWeb News) – Metabolon has reeled in $6 million in new Series C financing from new investors Syngenta Ventures and Fletcher Spaght Ventures, and from previous investors, bringing the total funding for the round to $12.3 million, the company said today.

The Research triangle Park, NC-based metabolomic diagnostics company also said that it has agreed to expand an earlier research collaboration with Syngenta, and that Syngenta Ventures VP Carol Marina and Fletcher Spaght VP Guy Fish have joined its board of directors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.